Diabetic Nephrology

Diabetic Diabetic nephropathy (DN) is typically defined by macro albuminuria—that is, a urinary albumin excretion of more than 300 mg in a 24-hour collection—or macro albuminuria and abnormal renal function as represented by an abnormality in serum creatinine, calculated creatinine clearance, or glomerular filteration filtration rate (GFR). Clinically, diabetic nephropathy is characterized by a progressive increase in proteinuria and decline in GFR, hypertension, and a high risk of cardiovascular morbidity and mortality. Diabetic nephropathy is a clinical syndrome characterized by the following: Proteinuria was first recognized in diabetes mellitus in the late 18th century.

  • Diabetic Microvascular Complications, Diabetic Nephropathy
  • Nephropathology and pathogenesis of diabetic nephropathy
  • Contrast nephropathy, uric acid nephropathy
  • Diabetic glomerulosclerosis, IgA nephropathy
  • HIV associated nephropathy
  • Glycemic control, diabetic ketoacidosis

Related Conference of Diabetic Nephrology

June 26-28, 2017

12th Global Nephrologists Annual Meeting

London, UK
July 06-07, 2017

12th Annual Conference on Nephrology & Urology

Kuala Lumpur, Malaysia
August 28-30, 2017

15th Annual Congress on Nephrology & Therapeutics

Philadelphia, USA
August 28-30, 2017

2nd Annual Kidney Congress

Philadelphia, USA
October 02-03, 2017

16th European Nephrology Conference

Barcelona, Spain
Oct 09-11, 2017

World Nephrology Congress

Osaka, Japan
October 18-19, 2017

13th World Nephrology Conference

Dubai,UAE
December 04-05 2017

17th Annual Conference on Nephrology

Dallas, Texas, USA

Diabetic Nephrology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in